If your child needs a stronger prescription year after year, you are not alone, and acting on it is exactly the right instinct. The faster a child's nearsightedness progresses, the higher their lifetime risk of serious eye problems like retinal detachment and glaucoma, which is why slowing it matters. Mudgil Eye Associates offers myopia control for Glen Mills families about 18 minutes away via Route 202 or Route 1, with both FDA-approved MiSight contact lenses and low-dose atropine, guided by a Johns Hopkins fellowship-trained pediatric ophthalmologist and a residency-trained pediatric optometrist. We are a complete MD-and-OD team, not an optometry-only office, so if anything beyond myopia ever comes up, expert care is already in place.
MiSight is an FDA-approved daily contact lens proven to slow the progression of myopia in children. Your child wears it during the day, and it both corrects vision and helps keep the prescription from climbing as quickly. We are listed on the manufacturer's official provider locator.
Dr. A. Vijay Mudgil completed his pediatric ophthalmology fellowship at the Wilmer Eye Institute, Johns Hopkins, and our optometrist provides residency-trained pediatric care. Your child's myopia plan is overseen by genuine pediatric eye specialists, not a general optical shop.
For children who are not ready for contact lenses, we also offer low-dose atropine eye drops, a simple nightly drop widely used to help slow myopia progression. We help you choose the approach that fits your child best, and some children do well with a combination.
Unlike a standalone optometry office, we are a complete MD-and-OD practice. A fellowship-trained pediatric ophthalmologist works alongside our optometrist, so if your child ever needs more than myopia control, surgical-level expertise is already part of their care.
A question we hear often from Glen Mills parents is simply, "When should we start?" Timing matters with myopia, because the childhood years are when most progression happens, and catching it early gives a control plan the most room to work. Many families make the short drive to our West Chester office for a first evaluation precisely because they noticed an early sign and wanted to act rather than wait.
Children do not always tell you they cannot see well, because they assume blurry distance vision is normal. Watch for squinting at the television or whiteboard, sitting unusually close to screens, holding books very near the face, frequent eye rubbing, or a dip in classroom performance that does not match a child's ability. A first prescription that lands earlier than a parent expected, or one that jumps noticeably between annual exams, is also a signal worth taking seriously.
Myopia tends to progress fastest during the early years after it appears, and a child who becomes nearsighted at a young age has more growing years ahead in which the eye can elongate. Beginning a control plan early does not stop normal eye development, but it can slow the pace of progression during this active window. The earlier we establish a baseline and begin monitoring, the sooner we can act if the prescription starts climbing quickly.
There is no single magic age, because readiness depends on the child and the method. Low-dose atropine drops, commonly 0.01% to 0.05% and used off-label, can be appropriate for younger children who are not ready to handle contacts. MiSight 1 day contact lenses are FDA-approved to slow progression and are generally introduced around ages 8 to 12, when many children can manage daily lenses. Orthokeratology is another overnight option we may discuss. We match the method to the child's age, prescription, and maturity rather than forcing a one-size approach.
Even before any treatment begins, an early visit lets us establish a clear baseline. By measuring the prescription and tracking it over time, Dr. Mudgil, a board-certified ophthalmologist with Johns Hopkins/Wilmer fellowship training, and our optometric team can tell the difference between expected stability and concerning progression. That distinction guides when to begin treatment and how aggressively. Acting early matters because higher myopia is associated with greater lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.
It is never too early to have vision checked. If you notice signs, an evaluation is worthwhile at any age.
Yes. An early, fast-changing prescription is exactly when a control conversation makes sense.
Drops like atropine can suit younger children, while contact-lens methods usually start around ages 8 to 12.
Regular monitoring against a baseline lets us see the rate of change clearly.
Most Glen Mills families are seen within one to two weeks for an initial myopia evaluation. Call 610-429-3004 or schedule online, and we will help you get ahead of your child's nearsightedness.